Demystifying traditional Chinese medicine for conservationists could be the key to better protecting endangered species like pangolins, tigers and rhino, according to University of Queensland-led researchers.
UQ PhD candidate Hubert Cheung said efforts to shift entrenched values and beliefs about Chinese medicine are not achieving conservation gains in the short term.
He said a better understanding of traditional practices was critical for conservationists to form more effective strategies.
“The use of endangered species in traditional Chinese medicine threatens species’ survival and is a challenge for conservationists,” Mr Cheung said.
“Pushing messages of inefficacy, providing various forms of scientific evidence or promoting biomedical alternatives doesn’t seem to be drastically influencing decisions and behaviours.
“And, although many practices and treatments continue to be criticised for lacking scientific support, the World Health Organization approved the inclusion of traditional Chinese medicine in its global compendium of medical practices last year.
“The challenge now is for conservationists to work proactively with practitioners and others in the industry to find sustainable solutions.
“However, most conservation scientists and organisations are unfamiliar with traditional Chinese medicine, which makes it difficult to devise effective and culturally-nuanced interventions.”
The researchers have examined the core theories and practices of traditional Chinese medicine, in a bid to make it more accessible.
They hope their study – and the nuances within – will influence policy and campaigning.
“Today, traditional Chinese medicine is formally integrated into China’s healthcare system, and has been central to China’s response to the ongoing pandemic,” Mr Cheung said.
“In fact, the Chinese government’s COVID-19 clinical guidance has included recommendations for the use of a product containing bear bile, which has raised concerns among conservation groups.”
UQ’s Professor Hugh Possingham said traditional Chinese medicine was now not only entrenched in the social and cultural fabric of Chinese society, but also gaining users elsewhere.
“A better understanding of traditional Chinese medicine will empower conservationists to engage more constructively with stakeholders in this space,” Professor Possingham said.
“We’re hoping that this work can help all parties develop more effective and lasting solutions for species threatened by medicinal use.”
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.
1. How is this virus different?
Unlike the coronavirus responsible for the 2002-2003 outbreak in Asia of severe acute respiratory syndrome, or SARS, this new one can spread via people who are infected but have yet to develop symptoms, or don’t at all. The U.S. Centers for Disease Control and Prevention estimates that 40% to 45% of SARS-CoV-2 infections occur without symptoms. A study by researchers at the Yale School of Public Health’s Center for Infectious Disease Modeling and Analysis found “silent” transmitters are responsible for more than half of the cases in Covid-19 outbreaks. What’s more, the new virus has a relatively long incubation period — the time between infection and the appearance of symptoms — enabling it to spread silently in a community before being detected. The interval is about five to six days compared with two days for the flu, which spreads the same way and is the most common cause of pandemics. The stealthy nature of the coronavirus wasn’t well understood at first and contributed to the staggered and uneven quality of the response.
Read more: Why ‘Silent Spreaders’ Make Coronavirus Hard to Beat: QuickTake
2. Why wasn’t it contained?
On Jan. 23, China imposed the most extensive quarantine in known history in Hubei province, where the outbreak began in the capital Wuhan, an industrial city of 11 million. By then, however, the virus had been seeded in other places. Starting in early February, many countries introduced travel bans but not before the virus had reached around the world. Governments issued stay-at-home orders and mandated “social distancing” to “flatten the curve” of new infections. But the economic toll propelled reopenings that in many places brought a surge in new cases, sometimes followed by new movement restrictions. It took months for some governments to recommend or mandate that people wear masks in public to counter the virus’s silent spread, and many still haven’t done so.
Read more: Mask or No Mask? And Which Kind? What the Experts Say: QuickTake
3. What’s the biggest mystery about the virus?
One major question is whether those who get the coronavirus emerge with immunity. Generally speaking, infections prompt the body to develop antibodies that protect against reinfection, although there are notable exceptions such as HIV and malaria. By mid-year a slew of antibody test kits were available, including some that could be taken at home. Many tests, however, weren’t reliable. What’s more, researchers still don’t know whether the presence of antibodies means someone has immunity, or how long that protection might last. With the main coronaviruses that cause the common cold, immunity generally doesn’t last very long. In Hong Kong, a man tested positive for the coronavirus in late August after recovering from a different strain in April, in what scientists said was the first documented case of reinfection. The man had no symptoms the second time, however, suggesting his immune system provided some protection, according to doctors. Dozens of reinfections have since been reported, according to a tracker maintained by
Primo Nutraceuticals Inc. signs a Memorandum of Understanding for Exclusive Rights to Sell Rapid (Colloidal Gold Method) COVID-19 Test Kits in Canada
COVID-19 Test Kits
COVID-19 Test Kits
VANCOUVER, British Columbia, Oct. 21, 2020 (GLOBE NEWSWIRE) — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF ) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (” PRIMO ” or the “Company”) announces the signing of a Memorandum of Understanding (MOU) with Neo-Nostics ™ (Suzhou) Bioengineering Co. Ltd. Of Su Zhou City, China (“Neo-Nostics”) as the official trade representative for Neo-Nostics ™ with the exclusive rights to apply for licensing and to market and sell the following COVID-19 production Canada: Neo-Nostics ™ 2019-nCoV IgG/IgM Rapid Test Kit (Colloidal Gold Method) (Test Kit).
The Memorandum of Understanding between Primo and Neo-Nostics ™, is effective as of October 13, 2020. Upon successfully receiving product license and approval by Health Canada, Neo-Nostics ™ will grant Primo with “Official Dealer/Distributor Status” in Canada.
The Neo-Nostics ™ 2019-nCoV IgG/IgM Rapid Testing Kit is currently registered with the FDA. Primo will be submitting the application for approval to Health Canada immediately. Neo-Nostics ™ has committed to supporting Primo’s efforts to obtain and maintain all necessary certifications and approvals for the sale and marketing of the Test Kits in Canada by granting access to all necessary documentation and clinical studies concerning the Test Kits.
Follow the link for a video demonstration: http://www.neo-nostics.com/skin/images/mp40.mp4
About the Neo-Nostics ™ Rapid Test Kits
The Neo-Nostics ™ 2019-nCoV Antibody Detection Reagent Kit (Colloidal Gold Method) has the advantage of rapidity, convenience, high accuracy, and can make up for the shortcomings of professional requirements, time consumption and low positive detection rate of PCR nucleic acid detection, and can be used as an important supplementary detection method for the diagnosis of coronal pneumonia.
Through detection and calculation, it is found that the comprehensive accuracy rate of the Neo-Nostics ™ 2019-nCoV IgM Detection Reagent is higher than 95%.
During the worst period of the epidemic in China, the reagent kit was donated to hospitals and the CDC in the most severely infected areas of Hubei for clinical auxiliary diagnosis. At present, the verification reports made by three clinical units prove that the positive detection rate of clinically confirmed cases has reached 92%, which has exceeded the general detection effect. Not only negative or positive results can be detected, but also the early, middle and or recovery period of virus infection can be distinguished by the positive strength of IgM or IgG.
Source: Clinical study report conducted by the Institute of Virology, in the capital city of Hubei, China and The Chinese Academy of Sciences in Beijing, China.
DISCLAIMER: “The Company is not making any express or implied claims that it has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time”.
Clinical Applications of Reagents
This reagent has been used by professionals in China since February 2020 in an area that was the hardest hit and impacted most severely by COVID-19, in the form of clinical auxiliary diagnosis.
The reagent kit was clinically verified by several professionals, hospitals, and universities respectively, and